Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current Status of the Use of Multifunctional Enzymes as Anti-Cancer Drug Targets

21 Dec 2021

Abstract excerpt

Fighting cancer is one of the major challenges of the 21st century. Among recently proposed treatments, molecular-targeted therapies are attracting particular attention. The potential targets of such therapies include a group of enzymes that possess the capability to catalyze at least two different reactions, so-called multifunctional enzymes. The features of such enzymes can be used to good advantage in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Histone Deacetylase Inhibitors Research
Share to Peptidase Inhibition and Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35056904
DOI: 10.3390/pharmaceutics14010010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current Status of the Use of Multifunctional Enzymes as Anti-Cancer Drug TargetsPMID 35056904Read ↗

Glycolysis rate-limiting enzyme PFKP: A pan-cancer predictor for prognostic significant, immunological correlation, and drug sensitivity predictionSemantic proximity Read ↗

Current Development and Application of Anaerobic Glycolytic Enzymes in Urothelial Cancer.Semantic proximity Read ↗

A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the SpotlightSemantic proximity Read ↗

Inhibitors of Mutant Isocitrate Dehydrogenases 1 and 2 (mIDH1/2): An Update and Perspective.Semantic proximity Read ↗

Wild-Type IDH Enzymes as Actionable Targets for Cancer TherapySemantic proximity Read ↗

The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulationSemantic proximity Read ↗

The roles of IDH1 in tumor metabolism and immunity.Semantic proximity Read ↗

Targeting NAD-dependent dehydrogenases in drug discovery against infectious diseases and cancerSemantic proximity Read ↗

The Emerging Roles of the Metabolic Regulator G6PD in Human CancersSemantic proximity Read ↗

6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancerSemantic proximity Read ↗

Thymidine phosphorylase in nucleotide metabolism: physiological functions and its implications in tumorigenesis and anti-cancer therapySemantic proximity Read ↗

The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic targetSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.